Shares of Eden Research plc (LON:EDEN – Get Free Report) traded up 2.8% during mid-day trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares were traded during trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Price Performance
The stock has a market capitalization of £19.73 million, a PE ratio of -200.00 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The stock’s 50-day moving average is GBX 3.88 and its 200 day moving average is GBX 4.01.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Business Services Stocks Investing
- What Does the Future Hold for Eli Lilly?
- About the Markup Calculator
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
